M&A Deal Summary |
|
|---|---|
| Date | 2024-03-15 |
| Target | Creapharm’s Clinical & Commercial Packaging and Bioservices Business |
| Sector | Packaging |
| Buyer(s) | Myonexus Therapeutics |
| Sellers(s) | Creapharm |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2017 |
| Sector | Life Science |
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a provider in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics was founded in 2017 and is based in New Albany, Ohio.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Packaging M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-10 |
SaveWay
Newark, Delaware, United States SaveWay is a local community resource for affordable, non-sterile compounded medications. The Company offers custom sterile and non-sterile compounded medications that can be personalized based on dose or delivery system. SaveWay was founded in 2001 and is based in Newark, Delaware. |
Buy | - |
Creapharm is a global clinical trial supply management company that supports clients from the Pharma and Biotech with customized solutions. The company provides cold-chain management and recently developed ultra-cold solutions to handle biologicals and ATMP supply chain management. For marketed health products, it offers expert commercial packaging services to pharmaceutical and food supplement industries. Creapharm is based in Reims, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Packaging M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
